During the last session, Aspira Women’s Health Inc (NASDAQ:AWH)’s traded shares were 1.28 million, with the beta value of the company hitting 1.49. At the end of the trading day, the stock’s price was $0.28, reflecting an intraday loss of -9.97% or -$0.03. The 52-week high for the AWH share is $5.00, that puts it down -1685.71 from that peak though still a striking 14.29% gain since the share price plummeted to a 52-week low of $0.24. The company’s market capitalization is $4.95M, and the average trade volume was 115.98K shares over the past three months.
Aspira Women’s Health Inc (AWH) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 1.00. AWH has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.22.
Aspira Women’s Health Inc (NASDAQ:AWH) trade information
Aspira Women’s Health Inc (AWH) registered a -9.97% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -9.97% in intraday trading to $0.28, hitting a weekly high. The stock’s 5-day price performance is -26.32%, and it has moved by -51.46% in 30 days. Based on these gigs, the overall price performance for the year is -94.11%.
The consensus price target of analysts on Wall Street is $3.3, which implies an increase of 91.52% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3.3 and $3.3 respectively. As a result, AWH is trading at a discount of -1078.57% off the target high and -1078.57% off the low.
Aspira Women’s Health Inc (AWH) estimates and forecasts
In the rating firms’ projections, revenue will increase 20.17% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 3M as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 5M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 2.13M and 2.15M respectively. In this case, analysts expect current quarter sales to grow by 40.85% and then jump by 132.23% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 5.77%. While earnings are projected to return 33.70% in 2025.
AWH Dividends
Aspira Women’s Health Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
